943141-73-9Relevant academic research and scientific papers
Heteroatom-substituted analogues of orphan nuclear receptor small heterodimer partner ligand and apoptosis inducer (E)-4-[3-(1-adamantyl)-4- hydroxyphenyl]-3-chlorocinnamic acid
Xia, Zebin,Farhana, Lulu,Correa, Ricardo G.,Das, Jayanta K.,Castro, David J.,Yu, Jinghua,Oshima, Robert G.,Reed, John C.,Fontana, Joseph A.,Dawson, Marcia I.
experimental part, p. 3793 - 3816 (2011/08/06)
(E)-4-[3'-(1-Adamantyl)-4'-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces the cell cycle arrest and apoptosis of cancer cells. Because its pharmacologic properties-solubility, bioavailability, and toxicity-required improvement for translation, s
An adamantyl-substituted retinoid-derived molecule that inhibits cancer cell growth and angiogenesis by inducing apoptosis and binds to small heterodimer partner nuclear receptor: Effects of modifying its carboxylate group on apoptosis, proliferation, and
Dawson, Marcia I.,Xia, Zebin,Liu, Gang,Fontana, Joseph A.,Farhana, Lulu,Patel, Bhamik B.,Arumugarajah, Sankari,Bhuiyan, Mohammad,Zhang, Xiao-Kun,Han, Young-Hoon,Stallcup, William B.,Fukushi, Jun-Ichi,Mustelin, Tomas,Tautz, Lutz,Su, Ying,Harris, Danni L.,Waleh, Nahid,Hobbs, Peter D.,Jong, Ling,Chao, Wan-Ru,Schiff, Leonard J.,Sani, Brahma P.
, p. 2622 - 2639 (2008/02/04)
Apoptotic and antiproliferative activities of small heterodimer partner (SHP) nuclear receptor ligand (E)-4-[3′-(1-adamantyl)-4′- hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC), which was derived from 6-[3′-(1-adamantyl)-4′-hydroxyphenyl]-2-naphthalenec
